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The connective
tissue stroma of malignant
tumors is
a newly
formed
tissue that supports
the growth
and
progression
of neoplastic
cells. Proteoglycans
are intrinsic
components
of this complex
structure
and molecular
changes
in this class of macromolecules
can
significantly
affect
behavioral
properties
of transformed
cells. We report
that human
colon carcinoma
contained
increased
levels of a chondroitin
sulfate proteoglycan
that exhibited
an altered glycosaminoglycan
structure
in which 0- and 6-sulfated
units, as detected
by specific
monoclonal
antibodies,
predominated.
Proteoglycans
with such epitopes
were localized
primarily
to the connective
tissue stroma surrounding
the tumor
cells but not to the tumor cells themselves
or the native,
non-cancerous
connective
tissue. Analysis
of mRNA
encoding
PG-40,
the main chondroitin
sulfate proteoglycan of colon tissue, revealed
a 7-fold increase
in the
two transcripts
encoding
this gene product.
This increase was evident
whether
the data were normalized
to total RNA content
or &actin
mRNA
levels.
The
altered
steady state levels of PG-40
mRNA
did not
correlate
with any significant
gene amplification
or
rearrangement
of PG-40 in human colon cancer. However, when
genomic
DNA was tested for degree
of
methylation,
the colon
carcinoma
tissue showed
a
marked
hypomethylation
of PG-40 gene locus, a finding that has been associated
with increased
gene activation.
Interestingly,
PG-40 gene was also hypomethylated in cultured
colon fibroblasts,
which express PG40, but not in colon carcinoma
cells which
do not
express
this gene. These results indicate
that specific
proteoglycan
changes
occur in colon carcinoma
and
that these alterations
are the product
of stromal
cells
that are topologically
associated
with and functionally
respondent
to the growing
malignant
cells. This is the
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first evidence
that enhanced
PG-40
expression
in a
human malignant
tissue is associated
with a hypomethylated
gene and suggests
that the control
of PG-40
gene expression
may represent
an important
factor in
the progression
of colon carcinoma.

The degree of local tissue invasion by colorectal cancer, the
second most common cancer in the western industrialized
societies, is directly correlated with the clinical outcome (1).
In the vast majority of cases, the invasion of the colonic wall
is preceeded by an exophytic growth of neoplastic cells and
stromal elements within the intestinal
lumen (2). It is noteworthy that about half of the neoplastic mass is composed of
stromal elements, primarily
fibroblasts,
smooth muscle, and
endothelial
cells, which together provide the necessary requirements
for tumor growth and progression
(3). Proteoglycans are intrinsic constituents
of this newly formed connective tissue;
and, particularly
because of their complex polyanionic nature, they have been implicated
in a number of
biological
processes. Proteoglycans
form a molecular
sieve,
are responsible for retaining water, act as growth promoting
agents, operate as receptors for matrix molecules, and influence the attachment
and migration
of cells along defined
routes (4-7). It is conceivable, therefore, that the newly synthesized proteoglycan-enriched
milieu that accompanies colon
carcinoma can enhance the proliferation
of this specific tumor
by providing
a favorable growth environment.
The main hypothesis of our research is that the structure
and formation of the tumor matrix is under the direct control
of the neoplastic cells and, through a feedback loop, altered
proteoglycan
composition
can influence the behavior of tumor
cells. This hypothesis is based in part on our observation
that
human colon carcinomas
have elevated amounts of a structurally altered chondroitin
sulfate that results from the abnormal production
of these molecules by the connective tissue
surrounding
the neoplastic cells (8, 9). These changes could
be partly reproduced
in vitro using either tumor metabolites
(10) or co-cultures of colon carcinoma and normal mesenchyma1 cells derived from human colon (11).
We have now extended these studies using immunological
and molecular biological probes specific for chondroitin
sulfate proteoglycan.
The results indicate that previously undetected qualitative
and quantitative
changes in this gene product exist and further suggest that the aberrant expression of
this proteoglycan
occurs solely in connective
tissue closely
associated with neoplastic cells. We further show for the first
time that enhanced expression of PG-40, determined by West-
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ern and Northern
blotting, is associated with hypomethylation of PG-40 gene locus, a DNA change known to be directly
linked to gene activation. Our results raise the novel possibility that neoplastic-induced
demethylating
events may affect
specific proteoglycan
genes and offer a molecular explanation
for the previously
reported proteoglycan
alterations
in this
human neoplasm.
EXPERIMENTAL

PROCEDURES

Tissue Preparation
and Proteoglycan
Extraction-Colectomy
specimens, obtained
immediately
after surgery,
were opened
longitudinally, the surface was gently washed with isotonic
saline, and samples
were taken from tumor
and normal
appearing
mucosa.
In all cases,
the diagnosis
of adenocarcinoma
was made using endoscopic
biopsy
prior to resection.
The samples were quickly
frozen in liquid nitrogen
and then transfered
to a -75 “C freezer. A total number
of 23 normal
colon and 24 colon carcinoma
samples
were studied.
In addition,
a
benign colonic polyp, human colon fibroblasts,
and colon carcinoma
(10) cells were studied.
The number
of normal
and neoplastic
tissue
samples
studied
by various
methodologies
is indicated
under
“Results.”
For proteoglycan
analysis,
tissue aliquots
(100-500
mg) were
homogenized
in 4 M guanidine
HCl, 0.5 M sodium
sulfate,
pH 5.8,
containing
0.1 M NaCl, 2% Triton
X-100 and various
protease
inhibitors (12). Aliquots
of [YS]sulfate-labeled
heparan
sulfate proteoglycan isolated
from human
colon carcinoma
cells (12) were added to
monitor
recovery
during the subsequent
purification
steps. Samples
were cleared by centrifugation
a 10,000 X g for 1 h at 4 “C and purified
by sequential
Sephadex
G-50 and DEAESephacel(l2).
Recovery
of
the radiolabeled
carrier proteoglycan
exceeded
90%.
MultLple
Western
Blotting-Agarose-acrylamide
gel electrophoresis, trans-blotting
to nitrocellulose,
multiple
immunoblotting,
and
subsequent
visualization
with ‘Z51-labeled
secondary
antibodies
was
done as described
(13). This technique
has the advantage
of analyzing
small samples
of tissue with quantitative
recovery
and permanent
trans-blot
that can be probed with various
antibodies
before and after
enzymatic
removal
of glycosaminoglycans
(13). The following
monoclonal antibodies
were used: (i) CS-56, directed
against
native chondroitin sulfate (14); (ii) 2B6, directed
against chondroitin
4-/dermatan
sulfate (15); (iii) 3B3, directed
against chondroitin
6-sulfate
(15); (iv)
lB5, directed
against chondroitin
O-sulfate
(15), and (v) 7D4 and 6C3,
directed
against native/oversulfated
chondroitin
sulfate
(16, 17). In
addition,
we used a monospecific
antibody
raised against the amino
terminal
peptide of PG-40
(18). Multiple
immunoblotting
was made
possible
through
removal
of antibodies
with 3 M sodium thiocyanate,
0.5% 2+mercaptoethanol,
0.5% Tween 20, pH 9.5. The exposure
of
the trans-blots
to this chaotropic
solution
appears
to have no effect
on the immobilized
proteoglycans
(13). To visualize
unsaturated
A
4,5 glcAgalNAc
O-SOS, 4-SO*,
or 6-SO,
residues
attached
to the
protein
core, the membranes
were immersed
in 0.05 units of proteasefree chondroitinase
ABC in 10 ml of 0.2 M Tris buffer, pH 8.0, for 18
h at 37 “C. As shown before
(13), the deglycosylated
proteoglycans
are totally
retained
in the membrane
and can react with specific
antibodies.
Autoradiographs
were quantified
in a laser beam scanning
densitometer
(LKB
Instruments)
by comparing
the area under a scan
to that of a 250-ng bovine nasal cartilage
standard,
an AlDl
preparation containing
70 ng of uranic
acid. This amount
of standard
was
well within the range of a linear relationship
between
concentration
and absorbance.
The calculated
amounts
of proteoglycan
are therefore
estimates
based on the content
of epitopes,
reactive
with the various
antibodies,
as found in bovine nasal cartilage.
Zmmunohistochemical
Studies-To
investigate
the tissue expression and localization
of chondroitin
sulfate
proteoglycan
in human
colon
and colon
carcinoma,
the monoclonal
antibodies
described
above were tested on both deparaffinized
formaldehyde-fixed
or frozen sections.
Immunoperoxidase
staining
before and after chondroitinase ABC digestion
&as performed
as described
(15-17).
RNA Isolation,
Northern,
and Slot Blotting-Total
RNA was prepared from frozen
tissue pulverized
under liquid nitrogen
according
to the acid guanidinium
thiocyanate
method
(19) with the addition
of 10.5 mM vanadyl
ribonucleoside
complex
(Bethesda
Research
Laboratories).
RNA was also isolated
from human
colon fibroblasts,
colon smooth
muscle,
and carcinoma
cells using 6-8 T-150
Falcon
flasks (2-5 X 10’ cells/flask)
each. Poly(A+)
RNA was purified
on
oligo(dT)-cellulose
columns
(ZO), separated
by electrophoresis
in 1%
formaldehyde-agarose
gels (21), and transferred
to nylon membranes
(Hybond,
Amersham
Corp.). Denatured
RNA samples were analyzed

by slot blot using a Minifold
II apparatus
(Schleicher
and Schull)
and BA85 nitrocellulose
paper. Both nylon and nitrocellulose
membranes were treated
at 89°C for 2 h under vacuum
before prehybridization
and hvbridization
with a full-lenath
1.8-kb’
PG-40
cDNA.
The insert was excised by EcoRI digestion,ieparated
on 1.2% agarose
gel from the plasmid,
purified
by-GeneClean
(Bio 101, San Diego,
CA), and nick-translated
using [a’P]dCTP
to reach a specific
activity
>lOs cpm/pg
DNA
(22). To determine
more exactly
the amount
of
poly(A+)
RNA, the slot blots were hybridized
with a full-length
2.1kb cDNA
encoding
human
&actin
(23). All the membranes
were
prehybrized
at 65 ‘C for at least 5 h in 6 x SSC (1 X SSC = 0.15 M
NaCl,
15 mM sodium
citrate,
pH 7.0), containing
1 X Denhardt’s
solution,
0.1% sodium dodecyl
sulfate,
and 100 pg/ml salmon
sperm
DNA, and then hybridized
with 32P-labeled
probe for 18 h at 65 ‘C.
The membranes
were washed in 2 X, 1 X, and 0.5 X SSC for 30 min
each and subjected
to autoradiography
using intensifying
screens
at
-75 “C. After various
exposures,
autoradiograms
were quantified
by
densitometry
as described
above.
DNA
Isolation
and Southern
Blotting-High
molecular
weight
genomic
DNA was prepared
from 200 to 360 mg of tissue or from two
to four T-150 flasks of confluent
cells as described
(24). Because
of
the intrinsic
error in the solubilization
of concentrated
DNA solutions, equal amounts
of DNA were initially
digested
with restriction
enzymes
as indicated
below and run on 0.8% agarose
gels in the
presence
of ethidium
bromide
(21). The gels containing
digested
and
undigested
samples
were then
photographed
and each negative
scanned.
The results
showed
that the ratio of arbitrary
absorbance
units, determined
by densitometry
of the negatives,
to that initially
determined
by spectrophotometry
of DNA in solution
was relatively
constant
with S.E. of 27% (n = 8). In a tvpical
experiment,
20 erg of
DNA
were digested
with PstI, BgZII, and-ZZindIII
restriction
endonucleases
(5 unitslue
DNA each) for 12 h at 37 “C, separated
in 0.8%
agarose
gels, and blotted
onto nitrocellulose
(25). The blots were
hybridized
under high stringency
to the PG-40
cDNA
or to a fulllength
cDNA
encoding
the human
C-WC proto-oncogene
(26). To
determine
the degree of methylation
of PG-40,
DNA
was digested
with Z&a11 or MspI. HpaII
cleaves 5’-CCGG-‘3
sequences
only if the
internal
C is unmethylated
(27), whereas
MspI cleaves 5’-CCGG-3’
sequences
regardless
of C methylation
(28). In addition,
the Southern
blots of HpaIIand &&I-digested
DNA were hybridized
with @-actin
cDNA.
I .
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RESULTS

Proteoglycan Analysis and Western Blotting-Western
blot
analyses of DEAE-Sephacel-purified
proteoglycans
using well
characterized
monoclonal
antibodies against intact chondroitin sulfate (14) or distinct isomers (15-17) revealed a marked
increase in chondroitin
sulfate in the malignant
tissue (Fig.
1, A and B). In both normal (Fig. IA, lanes 24) and tumor
tissue (Fig. lA, lane 5), one broad band of chondroitin
sulfate
proteoglycan
was detected by monoclonal
antibody CS-56, a
probe directed against intact chondroitin
4- or 6-sulfate chains
(14). When the CS-56-reacted
trans-blots
were quantified
by
laserbeam densitometry
(Fig. lB), a 3-fold increase in chondroitin sulfate was detected in the tumor.
Following chondroitinase
ABC digestion, an enzymatic degradation that unmasks the three major isomeric epitopes of
chondroitin
sulfate attached to the protein core (8), significant
qualitative
and quantitative
changes were further detected.
By inspecting the autoradiographs
(Fig. IA, lanes 16-18)
it is
evident that colon carcinoma tissue had a higher concentration of epitopes reactive with monoclonal
antibody 3B3 directed against the chondroitin
B-sulfate isomer than the normal colon tissue (Fig. IA, lanes 13-15). A similar increase in
epitope reactivity of tumor tissue proteoglycan
was also observed with monoclonal
antibody
lB5 that reacts with chondroitin O-sulfate epitopes (not shown). In contrast, the relative
amount of chondroitin
4-/dermatan
sulfate, an epitope detected by monoclonal
antibody
2B6, was not appreciably
changed (Fig. IA, lanes 6-11). This major product was im’ The

abbreviation

used

is: kb, kilobase

pair(s).
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colon and
(A) of bovine nasal cartilage

of proteoglycans

in tissue

Western
blotting
proteoglycan (BC), normal
human colon (N), and colon carcinoma tissue (7’) using monoclonal
colon

carcinoma.

antibodies
against native chondroitin
sulfate chains (lanes I-5), chondroitin
4-/dermatan
sulfate
epitopes
(lanes 6-22),
or against
chondroitin
B-sulfate
epitopes
(lanes 13-19).
In order
to visualize
the
chondroitin
sulfate epitopes,
the trans-blots
were subjected
to chondroitinase
ABC (protease-free)
digestion
before antibody
reaction
(A,

lanes 6-19). Thus, lanes 6-19 represent chondroitin
covalently
nitrocellulose

attached
to the protein
membrane.
B and

autoradiograms
tration

of uranic

core which
C represent

sulfate epitopes

is immobilized
quantification

into the
of the

by laserbeam densitometry as related to the concenacid

(28%

of weight)

in

the

standard

cartilage

proteoglycan run in parallel.
munologically
related to PG-40, since it was visualized by the
antibody raised against the PG-40 protein core (not shown).
A minor faster moving band was evidenced following a longer
exposure. Both bands, however, were reactive with anti-PG40 antibody
(not shown), indicating
that the two species
varied in their degree of glycosylation.
When the chondroitinase ABC-treated
trans-blots
were quantified
by laserbeam
densitometry,
the relative amount of chondroitin
6-sulfate
epitope and O-sulfate epitope was increased 6.3- and 3-fold
(Fig. lC), respectively. Taken together, these results indicate
that colon carcinoma tissue contains elevated amounts of a
proteoglycan
which is structurally
and immunologically
related to PG-40, but with increased relative content of chondroitin 6- and O-sulfate epitopes.
Immunohistochemical
Studies-We
next examined the immunohistochemical
distribution
of native
protein-bound
chondroitin
sulfate chains (14), the three major chondroitin
sulfate isomers (15-17), or the PG-40 protein core (18). Both
normal and neoplastic epithelia were unreactive with all the
anti-chondroitin
sulfate proteoglycan
antibodies
(Fig. 2), indicating that these epithelial
cells express little or no chondroitin sulfate. In contrast, the connective tissue of normal
and malignant
colon expressed various degrees of immunoreactivity with all the antibodies tested. Strikingly,
the tissue
distribution
of the chondroitin
g-sulfate epitope (Fig. 2, B and
C) was markedly different from that of the chondroitin
4-/
dermatan sulfate epitope (Fig. 2, E-G). Whereas the latter

11391

epitope was present in both normal and malignant
stroma at
approximately
equal intensities (Fig. 2, E-G), the chondroitin
6-sulfate epitope was present almost exclusively in the connective tissue intimately
associated with the malignant cells
(Fig. 2B). The tumor stroma, although morphologically
indistinguishable
from native connective tissue (Fig. 2A), could be
clearly separated from the pre-existing
stroma by the high
concentration
of chondroitin
6-sulfate epitopes (Fig. 2B, UFrowheads). A similar distribution
was also observed for the
chondroitin
O-sulfate epitope (not shown) and the PG-40
protein core epitope (Fig. 2K). Two other monoclonal
antibodies, 7D4 and 6C3, which are comparable with the CS-56
in that they recognize native chondroitin
sulfate chains (16,
17), exhibited
a distribution
similar to that of chondroitin
4-/dermatan
sulfate (Fig. 2, H-0. A summary of the immunohistochemical
data is presented in Table I. These results
indicate that the changes detected biochemically
can be directly correlated with an increased deposition of chondroitin
6-sulfate and O-sulfate in the tumor-associated
stroma.
Analysis of RNA, Northern,
and Slot Blotting-We
next
examined whether the steady state levels of mRNA encoding
PG-40 protein core were altered in human colon carcinoma.
First, quantification
of total RNA extracted from normal and
tumor tissue showed a reproducible
2.5-fold increase in total
RNA in colon carcinoma (Fig. 3A). When equal amounts of
poly(A+) RNA were analyzed by Northern blotting (Fig. 3B),
the two major transcripts
of 1.9 and 1.6 kb typical of PG-40
(18) were observed in both normal and tumor samples. It was
evident, however, that the amount of PG-40 transcripts
was
markedly increased in the tumor (Fig. 3B, lane 2) as compared
with normal colon (Fig. 3B, lane 3). Similar transcripts
were
also observed in several mesenchymal
cells including
skin
fibroblasts
(Fig. 3B, lane 1), colon fibroblasts,
and smooth
muscle cells (not shown), but were not detected in WiDr colon
carcinoma cells, a cell line that does not express this gene
product (12). These findings are consistent with the notion
that PG-40 is a product expressed primarily
by connective
tissue cells (7) and are in close agreement with the immunohistochemical
data presented above.
Relative PG-40 transcript levels were measured by slot blot
hybridization
of RNA run in triplicate and further quantified
by laserbeam densitometry
and computer integration.
The
amount of specific PG-40 mRNA was increased nearly 3-fold
in the tumor tissue uis 6. uis the normal colon tissue when
normalized
on a milligram
of total RNA (Fig. 3C). However,
when the values were corrected for changes in total RNA
content (Fig. 3A) and expressed as relative hybridization/g
of
tissue (Fig. 30), there was a 7.4-fold increase in this transcript
in the tumor. Normalization
of the PG-40 mRNA levels to
human p-actin mRNA levels showed similar PG-40 mRNA
increases in colon carcinoma
tissue, since @actin mRNA
levels were not significantly
different from those of normal
colon (not shown).
These results indicate that the increase in chondroitin
sulfate proteoglycan
detected biochemically
and immunohistochemically
is associated with elevated steady state levels of
PG-40 mRNA.
Analysis of DNA and Southern
Blotting-To
investigate
further the molecular basis for the changes in PG-40 mRNA
levels described above, we purified genomic DNA from samples of normal colon (n = 6) and colon carcinoma (n = 8)
tissue and determined the relative amounts by scanning ethidium bromide-stained
agarose gels. In contrast to the RNA
content, the total amount of DNA did not significantly
vary
between normal
and tumor tissue (2.6-2.8 mg/g tissue).
Therefore, the changes reported for mRNA are equally sig-
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colon

carcinoma

immunostained

with

colon carcinoma tissue stained with
hematoxylin and eosin. B, a sequential section from the same block stained with 3B3 monoclonal antibody directed
against chondroitin 6-sulfate epitope; note the marked labeling of the tumor stroma by this antibody and the clear
demarcation (arrowheads)
from the native connective tissue; the malignant cells (asterisk)
are totally unreactive.
C, cross-section of normal colonic mucosa reacted with 3B3 monoclonal antibodies. D, control section in which
the specific antibody was omitted. E, vertical section of normal colon reacted with 2B6 monoclonal directed against
chondroitin 4-/dermatan sulfate epitopes; note the delicate distribution of this epitope in the interstitium of the
antibodies

to various

A,
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TABLE

Distribution

2B6
3B3
lB5
7D4
6C3
PG-40

chondroitin

I

epitopes in the stroma of normal and malignant
human
colon
tissue
The values represent
a semiquantitative
distribution
of chondroitin
sulfate proteoglycan
epitopes
in the stroma
of normal
human
colon and colon carcinoma
specimens.
The relative
intensity
of immunostaining
ranges
from
very strong
(ii++),
to weak (k), to undetectable
(-). A total of 23 normal
and 24 tumor
samples
were analyzed
immunohistochemically.
The first five monoclonal
antibodies
listed below recognize
either specific
disaccharide
stubs remaining
on the protein
core following
digestion
with chondroitinase
ABC (2B6, 3B3, and lB5) or the
native chondroitin
sulfate chains covalently
linked to the protein
core (7D4 and 6C3). The anti-PG-40
antibody
is
a monospecific
rabbit anti-peptide
antibody
generated
against eighteen
amino acid comprising
the amino terminus
of PG-40/decorin
protein
core, a region
that also contains
the glycosaminoglycan
binding
domain
(18). For
additional
details, see Fig. 2.
Antibody

of immunoreactive
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sulfate

Normal

Epitope
Chondroitin
4S/Dermatan
Chondroitin
6-S
Chondroitin
O-S
Native
chondroitin
sulfate
Native
chondroitin
sulfate
PG-40 urotein
core, “decorin”

Mucosa
sulfate

nificant when normalized
to total DNA content.
Genomic DNA was examined by Southern blot hybridization following digestion with PatI, BglII, and Hind111 restriction endonucleases.
Both the pattern and relative intensity of
PG-40 hybridization
was similar in normal and tumor tissue
(Fig. 4A), indicating
that there was no gross genomic alteration for the PG-40 locus in this human tumor, i.e. no significant chromosomal
rearrangement
or gene amplification.
A
relatively
limited number of fragments
(two to five) were
detected by PG-40 cDNA probe (Fig. 4A). These results are
similar to those obtained using the same restriction
endonucleases on human placental DNA (18) and suggest that not
more than one or two genes encode PG-40.
As a further control for the integrity of the purified DNA
and for the hybridization
data described above, we examined
Southern
blots of parallel DNA digests using a full-length
cDNA encoding c-src proto-oncogene,
a gene expressed by
variety of tissues (26). The c-src probe reacted intensely with
two major DNA fragments
only in the P&I-digested
DNA
(Fig. 4B). The pattern and relative intensity of the hybridization were similar in normal and tumor tissue (Fig. 4B),
indicating
no significant
genomic alteration
in the c-src and
further validating
the hybridization
with PG-40 probe described above.
Hypomethylation
of PG-40
Gene
in Colon
Cancer-It
has
been shown that gene activation is associated with a decrease
in DNA methylation,
a covalent modification
of the mammalian genome that occurs almost exclusively at the dinucleotide CG (29-31). Here we wanted to test whether PG-40 was
indeed activated via a decrease in methylation
and determine
whether DNA from actively growing colon fibroblasts
and
colon carcinoma cells showed similar changes. To test these
possibilities
we used two methylation-sensitive
restriction
endonucleases,
HpaII and MspI.
HpaII cleaves 5’-CCGG-3’
sequences only if the internal C is unmethylated
(27), whereas
MspI cleaves 5’-CCGG-‘3
regardless of the methylation
state
of the internal C (28). Southern blotting revealed that normal

+
f
+
++
++
+

Malignant
Submucosa
++

++
++

f
+

peritumorous
stroma
+++
++++
++++
+++
+++
++++

colon tissue gave relatively larger HpaII fragments than either
malignant
or benign tumor tissue (Fig. 5A, compare lanes 1
and 2 with lanes 3-6 or 9, respectively),
in spite of the fact
that the ethidium bromide-stained
gels showed no detectable
differences
in HpaII sensitivity
(not shown). Interestingly,
DNA isolated from cultured colon carcinoma cells (Fig. 5A,
lane 7) was resistant to HpaII in contrast to colon fibroblasts
(Fig. 5A, lane 8) in which a major band of about 7 kb appeared.
Restriction
fragments
generated by MspI (Fig. 5B) were
essentially invariant
among the tissues and cells examined.
This indicates that the changes in HpaII restriction
pattern
shown in Fig. 5A were due to the presence of the modified
base 5methylcytosine
in the PG-40 gene. Specifically,
six
different DNA fragments of about 7, 5.5, 3.8, 2, 1.2, and 0.85
kb were generated by MspI digestion. The first five fragments
were detected in all the tissues examined, whereas the 0.85kb fragment was present in about half of the specimens. These
results are consistent with genetic polymorphism,
rather than
with gene rearrangements,
since no differences were noted in
the restriction
fragments generated by other three enzymes
(cf. Fig. 4).
The degree of hypomethylation
of PG-40 gene (Fig. 6A)
was determined
by calculating
the absorbance
ratio of the
smaller HpaII fragments (group
II, Fig. 5A) to the that of the
total HpaII fragments (group
I plus group 11, Fig. 5A). The
Southern
blots were also hybridized
with human @-actin
cDNA and the degree of hypomethylation
calculated as above
(Fig. 6B). The PG-40 gene from colon carcinoma (n = 8) was
about three times more hypomethylated
than normal colon
(n = 5) (Fig. 6A), in contrast to that of /3-actin that showed
no significant
difference
(Fig. 6B). Colon carcinoma
cells
exhibited
the lowest degree of hypomethylation
(Fig. 6A),
consistent
with the fact that colon carcinoma
cells do not
express this gene product (12) and do not show any immunoreactivity
with anti-PG-40
antibody both in vitro and in
vivo (11). In contrast, human colon fibroblasts, which express
this product (lo), showed a significant
degree of hypometh-

lamina propria
and the submucosal
connective
tissue. F and G, sections
of tumor tissue reacted with 2B6 monoclonal
antibodies;
note the marked
reaction
of the tumor stroma
and the lack of reaction
of the malignant
epithelial
cells
(asterisk).
H, colon carcinoma;
I, normal
colon reacted
with 7D4 monoclonal
antibody
directed
against
native
chondroitin
sulfate;
notice again the stromal
labeling
and the intensity
in the tumor stroma.
J, control
section
for
7D4 antibody.
K, cross-section
of tumor tissue reacted
with monospecific
anti-peptide
antiserum
which recognizes
the amino terminal
peptide
of PC-40;
notice the stromal
distribution
similar
to the chondroitin
4- and 6sulfate
epitopes.
L, control
section
for anti-PG-40
antibodies
(A-L X 200). A summary
of the immunostaining
is provided
in Table I.
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FIG. 3. Analysis
of RNA
in normal
human
colon
and colon
carcinoma
tissue.
A, total amount
of RNA. B, Northern
blottings
of 10 wg of total RNA isolated from skin fibroblast
(lane I), and 5 fig
each of poly (A’) RNA from colon carcinoma
(lane 2) and normal
colon
(lane 3). The blots
were reacted
with a full-length
cDNA
encodmg
PG.40 under high stringency
as described
in detail under
“Experimental
Procedures.”
Notice the two transcripts
of 1.9 and 1.6
kb typical
of PG.40
m both colon fibroblasts
and colon tissues.
Similar
transcripts
were observed
m human
colon smooth
muscle
cells but not m colon carcinoma
cell RNA
(not shown).
Relative
hybridization
for PG.40
transcripts
was determined
by laserbeam
scannmg
densitometry
of slot blots run m triplicate
and expressed
as
absorbance
umts/mg
of RNA (C) or corrected
for changes
in total
RNA content
and expressed
as absorbance
units per gram of tissue
(I)). When the data were expressed
on d-actin
hybridization,
similar
increases
in PG-40 mRNA
levels were obtained
(not shown).

FIG. 4. Southern
blot
hybridization
analysis
of genomic
DNA
from normal
colon and colon carcinoma
tissue
with PG40 (A) or c-src
(B) cDNA.
Twenty
pg of genomic
DNA isolated
from normal colon (N) and tumor tissue (2’) was digested with various
restriction
endonucleases
(PstI, Bg211, and HindIII)
and reacted
with
“P-labeled
PG.40 cDNA
(A) or C-UC proto-oncogene
cDNA
(R). In
B, lanes 1, 4, and 7 are samples
digested
with PstI; lanes 2, 5, and 8
are samples
digested
with &III;
and lanes 3, 6, and 9 are samples
digested with HzndIII.
The size in kilobase
pairs of DNA markers
is
indicated
at the margins.
Notice
the presence
of DNA fragments
of
comparable
intensity
and pattern
in both normal
and tumor
tissue,
indicating
no significant
amplification
or rearrangements
of either of
these two genes.

ylation
(Fig. 6A). Finally, DNA isolated from an adenomatous
polyp exhibited a pattern of methylation
similar to the malignant tissue (Fig. 6A), suggesting that hypomethylation
is
associated with connective tissue activation and remodelling
occurring in neoplasia. Analysis of the data presented in Fig.
6B clearly show that the PG-40 values would not significantly
change if normalized
to /3-actin hybridization
values.
In summary, these results indicate that the expression of
PG-40 gene is activated in colon carcinoma tissue and provide
a plausible explanation
for the increased PG-40 mRNA levels
and proteoglycan
content in this tumor.
DISCUSSION

In this study we have used a variety
of immunological
and
molecular biological approaches to investigate changes in the
expression of chondroitin
sulfate proteoglycan
in human colon carcinoma.
The results show a marked increase in a
chondroitin
sulfate proteoglycan
with immunological
and
structural
characteristics
similar to the ubiquitous
PG-40
proteoglycan
(18), also named “decorin” for its ability to bind
and decorate collagen fibrils (7). The glycosaminoglycan
composition of tumor-associated
proteoglycans
appeared to be
altered, displaying increased levels of 0- and 6-sulfate epitopes
when compared with normal colon proteoglycans.
The tumor
distribution
of this gene product was also quite striking since
it localized predominantly
to the newly formed connective
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7 x 9

FIG. 5. Methylation
patterns
of PG-40
locus in normal
human colon,
colon carcinoma
tissue,
benign
colonic
polyp,
and
cultured
cells.
Twenty
pg of genomic
DNA
isolated
from normal
colon (N), colon carcinoma
tissue (Z’), WiDr
colon carcinoma
cells
(W), normal
human
colon fibroblasts
(F), or benign
adenomatous
polyp of colon (P) were digested
with HpaII
(A) or MspI (B) restriction endonucleases
and analyzed
by Southern
blotting
using ‘“Plabeled
PG-40
cDNA
insert.
The size in kilobase
pairs of DNA
markers
is indicated
in the margins.
Notice the presence
of relatively
smaller
fragments
in the HpaII-digested
DNA from the tumor tissue
uis d uis the normal
tissue. The ethidium
bromide
stained gel did not
show any detectable
change
among any of the DNA samples
(not
shown).
For additional
details, see Fig. 6.
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FIG. 6. Quantitation

of the degree
of hypomethylation
of
(A) and @-actin
(Ii) genes
in human
colon
tissue
and
colon
cells.
The degree of PG-40 hypomethylation was
obtained by calculating
the absorbance
ratio of group II (the smaller
molecular
-weight
HpaII
fragments
as indicated
in-Fig. 5A) to the
total (group I plus group 10 HpaII
fragments
from several
autoradiographs
of Southern
blots as described
before (34). The proportion
of
II/I s II was determined
for each digest and recorded
as percent
of
hwomethvlation.
The Southern
blots were heated at 100 “C in 0.1%
s&urn
dodecyl
sulfate,
exposed
overnight
to check
for complete
removal
of the probe, rehybridized
with p-actin
cDNA,
and quantitated for methylation
(B) as for the PG-40. The values for the normal
colon (n = 5) and colon carcinoma
(n = 8) represent
the mean f SE.
The values
for the remaining
samples
are the mean of duplicate
determinations.

PG-40
cultured

tissue surrounding
the tumor cells. The presence of this
nroteoglvcan
within the tumor stroma was clearlv demarcated
from the native connective tissue by using monoclonal
antibodies directed against the intact glycosaminoglycan
chains,
against the major chondroitinase
ABC-generated
disaccharide
epitopes, or against the amino terminal
peptide of PG-40
protein core. In contrast, in normal colon tissue, PG-40 proteoglycan was expressed at relatively
lower levels, was primarily associated with blood vessels, and was only focally
present in the interstitium.
These findings corroborate
our
previous histochemical
and autoradiographic
studies which
show a similar tissue distribution
of chondroitin
sulfate proteoglycans (8) and with our organ culture studies of human
colon carcinoma
which show enhanced synthesis of a small
chondroitin
sulfate proteoglycan
by the tumor tissue (9). It is
noteworthy
that similar tumor-associated
changes in connective tissue composition are also observed in distant metastases
of colon carcinoma
(2, 32) and in a number of carcinomas
(33) with mornhoeenetic
features similar to colon cancer. but
are absent in m&nant
neoplasms
that do not induce a
stromal response (3). This argues that the neoplastic-associated stromal changes are tumor-specific
and not just an
epiphenomenon,
i.e. a nonspecific
response of the host (see
below).
In the present studies we provide direct evidence that
proteoglycans
with immunological
and structural
character-
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istics related to PG-40 are indeed the major source of these
changes. We further show that the steady state levels of PG40 mRNA were significantly
elevated and that the total content of this specific transcript
was over seven times greater
than that of normal tissue, whether the values were normalized to total RNA content or @actin mRNA levels. Because
transformed
colon epithelial
cells do not express detectable
levels of PG-40 mRNA nor express the proteoglycan
in vitro
(11, 12), the present results imply that connective tissue cells
are stimulated
to produce this gene product. Since our data
are based on RNA extracted from whole tissue, it cannot be
excluded that the changes in PG-40 mRNA levels are related
to a greater number of connective tissue cells in the tumor.
However, previous morphometric
studies (8) have shown that
the various cellular compartments
of colon carcinoma tissue
are not significantly
different from the normal state.
Using Southern
blot hybridization,
we demonstrate
that
PG-40 gene was neither
significantly
amplified
nor rearranged. However, when we tested the degree of methylation
of the PG-40 gene using methylation-sensitive
and -insensitive restriction
endonucleases,
we found a 3-fold decrease in
the methylation
state of this gene in colon carcinoma tissue.
The specificity of these findings was validated by analysis of
B-actin methylation,
a gene that was equally hypomethylated
in normal and colon carcinoma tissue. The DNA of a variety
of genes has been found to be undermethylated
in cells and
tissues where they are expressed and to be methylated
when
they are not expressed (29-31). Methylation
of DNA is a
covalent modification
of the mammalian
genome, with about
70% of cytosine in CG sequences being methylated in normal
cells (29-31). Recent studies have shown a nonrandom
decrease in DNA methylation
of specific genes in various tumors
including
colon carcinoma
(34-36). In the present study, the
degree of hypomethylation
was not a general phenomenon,
since ethidium bromide-stained
gels before Southern blotting
revealed no significant
differences
in &a11 sensitivity
between normal and neoplastic colon. These data confirm previous reports (34, 36), and further stress that specific genes
show undermethylation
when tested by Southern
blotting,
even in the absence of a general hypomethylation
detectable
with less sensitive methods. Our results are the first to demonstrate a hypomethylation
in a gene encoding a ubiquitous
proteoglycan
and provide a plausible
explanation
for the
increased PG-40 mRNA levels and proteoglycan
content detected in this tumor.
Because several genes are undermethylated
to the same
degree in both benign and malignant
colonic neoplasms, it
has been proposed that hypomethylation
is a consistent DNA
alteration
of human colonic neoplasms and that this alteration precedes malignancy
(36). Implicit in these studies, however, is the concept that selective gene hypomethylation
derives from the clonal neoplastic
cells, whether
benign or
malignant,
and no effort has been put on determining
the
cellular source of these alterations.
In the present study, we
have attempted
to determine
the cellular source of PG-40
undermethylation
by comparing
DNA isolated from normal
and transformed
colon tissues with that of normal stromal or
transformed
epithelial
cells derived from human colon. All
the data point to a selective undermethylation
of PG-40 in
the neoplastic stromal cells, which correlates well with the
immunohistochemical
localization
of PG-40, rather than in
the neoplastic cells themselves.
An important
question that needs to be addressed is about
the specificity of these changes, that is, to what extent
these
DNA alterations
are due to a nonspecific
connective tissue
response associated with neoplastic growth. In this context,
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we have recently found’ in four different patients with ulcerative colitis, a chronic bowel disease characterized by active
inflammation and tissue remodelling (l), that PG-40 gene is
methylated to the same extent as normal colon. These results,
together with PG-40 hypomethylation in a benign adenomatous polyp of the colon described in this report, suggest a
significant degree of specificity for these DNA alterations and
that these changes are associated with or induced by a clonal
cell population.
The finding of PG-40 hypomethylation in proliferating
colon fibroblasts, but not in colon carcinoma cells, which do
not express PG-40 (12), is further evidence for a connective
tissue activation in response to tumor cytokines. This concept
is based on the fact that analogous changes in chondroitin
sulfate proteoglycan can be induced in vitro by either exposing
colon fibroblasts to soluble cytokines released by the colon
carcinoma cells (10) or by co-culturing colon carcinoma cells
with colon fibroblasts or smooth muscle cells (11). An additional regulatory mechanism could be provided by heparan
sulfate proteoglycan. This proteoglycan binds a variety of
growth factors (37), concentrates them in the extracellular
matrix, and protects them from proteolytic attack (38, 39).
Because colon carcinoma cells synthesize large amounts of
heparan sulfate proteoglycan (12,40), and these levels can be
further increased by exposing the cells to transforming growth
factor @,3it is conceivable that the enhanced expression of
PG-40 may be in turn induced
by growth
factors bound to the
heparan sulfate proteoglycan.
In conclusion, we believe that modulation of extracellular
matrix by neoplastic cells is an important step in tumor
progression because it provides a proteoglycan-enriched well
hydrated microenvironment which, by analogy with developmental systems, can favor the growth of tumor cells. Our
results provide a molecular explanation for the previously
reported proteoglycan changes in human colon carcinoma and
raise the novel possibility that demethylating events associated with or induced by a clonal cell population may affect
specific connective tissue genes.
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